Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: IBOGF )

0.0341 +0.0135 (+65.53%)
Streaming Delayed Price Updated: 9:30 AM EST, Feb 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 733
Open 0.0341
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0206
Today's Range 0.0341 - 0.0341
52wk Range 0.0040 - 0.0338
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More
Via Benzinga
Largest Psychedelic Stocks DOWN 8% Last Week; DOWN 22% So Far This Month
Today's article highlights the performance of the munKNEE Psychedelic Drug Stocks Index which tracks the six (6) largest psychedelic stocks researching the treatment of mental illnesses based on the... 
Via Talk Markets

Performance

YTD
+127.33%
+127.33%
1 Month
+100.59%
+100.59%
3 Month
+148.91%
+148.91%
6 Month
+752.50%
+752.50%
1 Year
+326.25%
+326.25%

More News

Read More
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD
Via Talk Markets
Psychedelic Drug Stocks Index Has A Good Week
Via Talk Markets
Psychedelic Drug Stocks Index Up Slightly This Week
Via Talk Markets
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD
Via Talk Markets
Universal Ibogaine Provides Update on Kelburn Recovery Center
Via IssueWire
Universal Ibogaine Provides Update on Kelburn Recovery Center
Via TheNewswire.com
Nick Karos to Present at H.C. Wainwright 1st Annual Mental Health Conference
Via Zexprwire
Nick Karos to Present at H.C. Wainwright 1st Annual Mental Health Conference
Via AB Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.